Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Organovo Holdings (ONVO)
NASDAQ:ONVO
RESEARCH TOOLSreports
Holding ONVO?
Track your performance easily
ONVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.32 - $1.74
Previous Close$0.35
Volume133.84K
Average Volume (3M)85.75K
Market Cap
$5.24M
Enterprise Value$3.22M
Total Cash (Recent Filing)$3.20M
Total Debt (Recent Filing)$1.17M
Price to Earnings (P/E)―
Beta0.99
Next Earnings
Aug 08, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.07
Shares Outstanding15,365,826
10 Day Avg. Volume205,298
30 Day Avg. Volume85,755
Standard Deviation0.22
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.46
Price to Sales (P/S)50.90
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue22.33
Enterprise Value/Gross Profit29.50
Enterprise Value/Ebitda-0.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Organovo Holdings News
PremiumCompany Announcements
Organovo Holdings Gains Approval for Key Strategic Moves
PremiumCompany Announcements
Organovo Holdings Grants Stock Options to Executive Chairman
PremiumCompany Announcements
Organovo Holdings Shares Corporate Update PresentationOwnership Overview
2.73% Insiders
3.00% Mutual Funds
10.64% Other Institutional Investors
81.58% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ONVO FAQ
What was Organovo Holdings’s price range in the past 12 months?
Organovo Holdings lowest stock price was $0.32 and its highest was $1.74 in the past 12 months.
What is Organovo Holdings’s market cap?
Currently, no data Available
When is Organovo Holdings’s upcoming earnings report date?
Organovo Holdings’s upcoming earnings report date is Aug 08, 2019 which is 1934 days ago.
How were Organovo Holdings’s earnings last quarter?
Organovo Holdings released its earnings results on May 22, 2019. The company reported -$22.951 earnings per share for the quarter, missing the consensus estimate of N/A by -$22.951.
Is Organovo Holdings overvalued?
According to Wall Street analysts Organovo Holdings’s price is currently Overvalued.
Does Organovo Holdings pay dividends?
Organovo Holdings does not currently pay dividends.
What is Organovo Holdings’s EPS estimate?
Organovo Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Organovo Holdings have?
Organovo Holdings has 15,365,826 shares outstanding.
What happened to Organovo Holdings’s price movement after its last earnings report?
Organovo Holdings reported an EPS of -$22.951 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Organovo Holdings?
Among the largest hedge funds holding Organovo Holdings’s share is ARK Investment Management LLC. It holds Organovo Holdings’s shares valued at N/A.
---
Organovo Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ONVO Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 214.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 3.2%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.65%
12-Months-Change
Fundamentals
Return on Equity
-206.69%
Trailing 12-Months
Asset Growth
-39.49%
Trailing 12-Months
Company Description
Organovo Holdings
Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
---
Technical Analysis
---